Alex Piré, Seeyond Head of Client Portfolio Management, joins Yahoo Finance's Alexis Christoforous and Brian Sozzi to discuss overall market outlook. ...
Miller Value Partners recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Miller Value Partners Opportunity Equity Fund posted a return of -38.4% for the quarter (net of fees), underperforming its benchmark, the S&P 500 Index which returned -19.6% in the same quarter. You should check out Miller […]...
Alicia Levine, BNY Mellon Chief Strategist, joins Yahoo Finance's The First Trade to discuss what's moving the markets around Thursday's opening bell. ...
Miller Value Partners recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Miller Value Partners Opportunity Equity Fund posted a return of -38.4% for the quarter (net of fees), underperforming its benchmark, the S&P 500 Index which returned -19.6% in the same quarter. You should check out Miller […]...
Miller Value Partners recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Miller Value Partners Opportunity Equity Fund posted a return of -38.4% for the quarter (net of fees), underperforming its benchmark, the S&P 500 Index which returned -19.6% in the same quarter. You should check out Miller […]...
(Bloomberg) -- U.S. Treasury Secretary Steven Mnuchin said the government shouldn’t shut down the economy again even if there’s another surge in coronavirus cases. Meanwhile, a second wave of infections in America is raising alarm after the overall count passed 2 million.In Britain, Prime Minister Boris Johnson is battling to contain a public split with his own top scientific advisers, after they warned the government must learn from the catalog of failures it made during the coronavirus crisis. Job losses continued to mount in the country.Moderna said it had selected a dose for a final-stage clinical trial of its vaccine that should begin in July and Regeneron Pharmaceuticals started human tests of a new antibody cocktail. Stocks tumbled after the Federal Reserve warned that the pandemic could inflict lasting damage.Key Developments:Virus Tracker: Cases pass 7.4 million; deaths exceed 417,300Trump’s slipping polls make GOP holding Senate more dauntingProtester in Australia tests positive...
Wall Street observers hoped recent gains signaled the arrival of blue skies, but the COVID-19 storm is thundering on. Stocks started shedding gains this week on fears of a possible second wave of coronavirus infections and a grim forecast for the economy from the Federal Reserve.A situation like this is tailor-made for defensive stock plays – and that will naturally bring investors to look at high-yield dividend stocks. But not all dividend stocks are created equal. Top analysts from Oppenheimer have chimed in – and they are recommending high-yield dividend stocks for investors looking to find protection for their portfolio. Using TipRanks database, we’ve pulled up the details on some of Oppenheimer's recommendations. These are stocks with a specific set of clear attributes, that frequently indicate a strong defensive profile: a high dividend yield, over 8%; a Moderate Buy consensus view; and a considerable upside potential -- over 20%. So let’s take a closer...
